In this study we have used a neutralizing TNFR1-specific antibody to assess the potential therapeutic role of TNFR1 inhibition in an inflammatory neurodegenerative disease using an animal model of MS. The gene discussed is TNFRSF1A; the disease is neurodegenerative disease.